Retatrutide is a novel synthetic peptide classified as a polyagonist drug, primarily designed for metabolic regulation. It targets multiple pathways in the body by acting as an agonist to three hormonal receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Initially developed for managing obesity, type 2 diabetes, and metabolic syndrome, its versatility has expanded its application into the fitness and bodybuilding industry.
By influencing energy balance, fat metabolism, and appetite regulation, Retatrutide provides a strategic edge for individuals seeking to optimize their fitness, body composition, and metabolic health.
